Service de radiologie, centre hospitalier Lyon-Sud, hospices civils de Lyon, 69310 Pierre-Bénite, France.
Service de neurologie-sclérose en plaques, pathologies de la myéline et neuroinflammation, centre de référence des maladies inflammatoires rares du cerveau et de la moelle (MIRCEM), hospices civils de Lyon, hôpital neurologique Pierre-Wertheimer, 69500 Bron, France; Inserm U1028, CNRS UMR5292, centre de recherche en neuroscience de Lyon, université Lyon-1, 69008 Lyon, France.
J Neuroradiol. 2021 Feb;48(1):28-36. doi: 10.1016/j.neurad.2020.04.006. Epub 2020 May 12.
To determine the diagnostic value of bright spotty lesions (BSLs) for aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (NMOSD), the predictive value of axial-BSLs for AQP4-IgG seropositivity, and the radio-clinical differences in NMOSD patients with and without axial-BSLs.
Retrospective study that included patients aged≥16 years, with a first acute spinal cord syndrome between 2005 and 2018 and abnormal spinal cord MRI with axial and sagittal T2 sequences. Patients with MRI findings consistent with compressive myelopathy were excluded. All spinal cord MRI were retrospectively evaluated for the presence of BSLs by 2 radiologists blinded to the diagnosis of acute myelopathy.
A total of 82 patients were included; 15 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients (NMOSD), and 67 other patients, considered as the other causes of myelopathy (OM) group. The specificity of axial-BSLs for NMOSD patients was 94.0% (95% CI [85.6 to 97.7]). The sensitivity was 40.0% (95% CI [19.8 to 64.3]). In the multivariable analysis, the only MRI characteristic associated with AQP4-IgG positivity was the presence of axial-BSLs (OR: 9.2, 95% CI [1.2 to 72.9]; P=0.022). In NMOSD patients, the median of cord expansion ratio was higher with axial-BSL (1.2, IQR [1.1-1.3]) than without axial-BSL (1.1, IQR [1.0-1.2]; P=0.046).
After a first acute spinal cord syndrome, the presence of axial-BSLs on spinal cord MRI seems very specific for NMOSD and seems to be a predictor radiological marker of AQP4-IgG positivity.
确定水通道蛋白-4 抗体阳性视神经脊髓炎谱系障碍(NMOSD)中亮点病变(BSL)的诊断价值、轴位 BSL 对 AQP4-IgG 阳性的预测价值,以及有无轴位 BSL 的 NMOSD 患者的放射临床差异。
回顾性研究纳入了 2005 年至 2018 年期间年龄≥16 岁、首次出现急性脊髓综合征的患者,并对其进行了异常的脊髓 MRI 轴位和矢状 T2 序列检查。排除了 MRI 结果与压迫性脊髓病相符的患者。由 2 名放射科医生对所有脊髓 MRI 进行回顾性评估,以评估存在 BSL 的情况,这 2 名医生对急性脊髓病的诊断均不知情。
共纳入 82 例患者;其中 15 例为水通道蛋白-4 抗体阳性 NMOSD 患者,67 例为其他被认为是脊髓病原因的患者(OM 组)。轴位 BSL 对 NMOSD 患者的特异性为 94.0%(95%CI [85.6 至 97.7])。敏感性为 40.0%(95%CI [19.8 至 64.3])。在多变量分析中,唯一与 AQP4-IgG 阳性相关的 MRI 特征是存在轴位 BSL(OR:9.2,95%CI [1.2 至 72.9];P=0.022)。在 NMOSD 患者中,轴位 BSL 存在的脊髓扩张比中位数较高(1.2,IQR [1.1-1.3]),而不存在轴位 BSL 的脊髓扩张比中位数较低(1.1,IQR [1.0-1.2];P=0.046)。
在首次出现急性脊髓综合征后,脊髓 MRI 上存在轴位 BSL 似乎对 NMOSD 非常特异,并且似乎是 AQP4-IgG 阳性的预测性放射学标志物。